US Patent Issued to Shenzhen Rhegen Biotechnology, Wuhan Rhegen Biotechnology on June 10 for "Cationic lipid compound and composition for delivery of nucleic acids and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,676, issued on June 10, was assigned to Shenzhen Rhegen Biotechnology Co. Ltd. (Shenzhen, China) and Wuhan Rhegen Biotechnology Co. Ltd. (Wuhan, China).

"Cationic lipid compound and composition for delivery of nucleic acids and use thereof" was invented by Yong Hu (Shenzhen, China), Yafei Li (Shenzhen, China) and Zhaoyu Hu (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present invention are a cationic lipid compound and a composition for delivery of a nucleic acid, and the use. The compound is represented by the following formula (I). Further provided in the present invention are the use of a nano-lipid particle usin...